FindTrial
Sign In

comparison of 0.75% Ropivaciane vs 0.5% Bupivacaine in spinal anesthesia in infraumblical surgeries.

“Comparative Evaluation of 0.75% Hyperbaric Ropivacaine versus 0.5% Hyperbaric Bupivacaine for Elective Infraumbilical Surgeries : A randomised controlled study. ?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041152
Enrollment
80
Registered
2022-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.75% hyperbaric Ropivacaine: patients in group I will receive 3ml of 0.75% hyperbaric Ropivacaine as spinal anesthesia Control Intervention1: 0.5% hyperbaric Bupivacaine: patients in g

Sponsors

DEPARTMENT OF ANESTHESIA RAJENDRA INSTITUTE OF MEDICAL SCIENCES RANCHI JHARKHAND
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists (ASA) physical status 1 and 2 of Age group between 18 - 60 years of age Undergoing elective infraumbilical surgeries.

Exclusion criteria

Exclusion criteria: Patient refusal, Bleeding disorder, Neurological disease, Local skin infection, Allergy to study drugs, Back deformities, Raised intracranial pressure, Patients on anticoagulant or antiplatelet therapy and ASA physical status >2

Design outcomes

Primary

MeasureTime frame
TIME FOR ONSET OF SENSORY BLOCKADE AT (T10) DERMATOME LEVEL, MAXIMUM SENSORY BLOCKADE ACHIEVED, TIME TO COMPLETE MOTOR BLOCKADE, TIME OF REGRESSION OF SENSORY BLOCKADE AND TIME TO REQUIREMENT OF RESCUE ANALGESIA Timepoint: UPTO 24 HOURS AFTER SURGERY—

Secondary

MeasureTime frame
Hemodynamic variations in both groups and Any adverse effects of the drugs used will be recorded Timepoint: till discharge—

Countries

India

Contacts

Public ContactWASIMUL HODA

RAJENDRA INSTITUTE OF MEDICAL SCIENCES RANCHI

wasu077@gmail.com8797770602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026